Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2022 Earnings Call Transcript

Ron Nixon: And so, yes, we have — we have four that are out there right now. And those are — those have been white papers that are over 80 patients in almost every instance. I think we have one new one by Gitelman. That was 50 plus patients. All of those showed excellent results in the surgical setting. There’s historical research as well that you know talks have been around in the wound form longer, and there’s some data out there on that. And then going forward, we do have several studies that will be very shortly being published. This is the time frame for a lot of the trade shows, and that’s typically a time where you’ll see those revealed. We haven’t at this point disclosed when those will be coming, but one will be presented at the SAWC.

There’s another one that will hit the manuscript. Manuscript will be submitted this week. And then that should be something we can announce fairly shortly. So there’s — there’s two right — right in our midst and a few that are just a little further out. And then we also are, of course, doing a research on BIAKOS BIASURGE in the additional product lines that we’ve added.

Operator: Thank you. As there are no further questions in queue, I will hand it back to Mr. Nixon for any closing comments.

Ron Nixon: Thank you very much. We really appreciate everybody’s attendance today. Thank you for the good questions. And we hope to continue to provide good results to you in the future. And thank you, everybody, for being a shareholder. Take care.

Zachary Fleming: Thank you.

Operator: Thank you. Ladies and gentlemen, this does conclude today’s call. You may disconnect your lines at this time and have a wonderful day and we thank you for your participation.